| Sign In to gain access to subscriptions and/or personal tools. |
Relationship of IL-2, IL-2R (CD25+), Soluble IL-2R and IL-4 with Disease Activity in SLE PatientsUnit of Rheumatology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Immunology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Immunology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Immunology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Immunology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Immunology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Internal Medicine, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain
Immunology, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, 14004 Cordoba, Spain The plasma levels of interleukin-4 (IL-4), interleukin-2 (IL-2), soluble receptor of IL-2 (IL-2R) and T cell expression of IL-2 receptor chain (CD25+) were determined in an attempt to relate these parameters with disease activity in systemic lupus erythematosus (SLE). IL-4, IL-2 and sIL-2R plasma levels of SLE patients were significantly higher than those of the control group (P<0.05) while CD25+ expression was similar in both groups. Only sIL-2R levels were significantly higher (P<0.05) in active than in inactive patients.
Key Words: Cytokines Autoimmune disease Lupus Immunossupression
Lupus, Vol. 2, No. 1 suppl,
257-260 (1993) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||